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Summary.-Chromosome studies have been made of 2 human colonic tumour lines
maintained as xenografts in immune-deprived mice. In both tumours human karyo-
types were retained, although progressive changes occurred during serial passage.
In one tumour, independent gain of a chromosome 19 was found in the stemline and
2 sidelines. In the other tumour there was selection for a sideline containing a parti-
cular deleted marker chromosome.
The advantages of chromosome analysis in a xenograft system, both for the study
of human solid tumour karyotypes and for monitoring the continued presence of the
human genome, are discussed.
HUMAN tumour xenografts are of
importance for the study of basic tumour
biology and for chemotherapeutic screen-
ing. Although systematic chromosome
studies of human tumour xenografts have
been attempted rarely, they have import-
ant contributions to make in the overall
study of these systems. It is, for example,
essential to know whether the established
graft has retained a human karyotype,
since there is evidence that hetero-
transplantation in immune-deprived mice
may occasionally induce tumours in the
host (Houghton, 1977).
The main difficulty in the study of
chromosomes from solid tumours is in
obtaining sufficient numbers of mitoses
of the technical quality required for
accurate analysis using modern banding
methods. A preliminary analysis of 6
human colonic tumour xenografts, under-
taken with the object of ensuring that the
karyotypes were human (Houghton, 1977)
suggested that such systems might over-
come this difficulty to some extent.
We describe here the cytogenetic
characteristics of 2 heterotransplanted
human colonic tumours, studied using
chromosome banding techniques at early
passages and again after up to 2 years of
transfer in immune-deprived mice.
MATERIALS AND METHODS
(1) The tumiour lines.-The 2 tumour lines
studied, designated HxGC3 and HxVRC5,
formed part of a larger series of colorectal
carcinomas established as xenografts in
immune-deprived CBA/lac mice (Houghton,
1977). HxGC3 was derived from a poorly-
differentiated adenocarcinoma of the trans-
verse colon (obtained from an untreated
61-year-old male patient who was alive and
well 16 months after surgery). HxVRC5 was
established from a poorly-differentiated
adenocarcinoma of the caecum (obtained
from an untreated 72-year-old male patient
who was lost to follow-up).
Details ofthe preparation ofthe host mice,
and tumour implantation methods have been
described (Houghton, Houghton and Taylor,
1977).
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(2) Chromosome studies.-Chromosome pre-
parations were made from HxGC3 at passages
3 and 11, and from HxVRC5 at passages 4
and 10.
When the implanted tumours had reached
-1-0 cm in size they were excised, minced,
using crossed scalpels, and incubatedin0.25%
trypsin in PBS at 37°C for 30 min. After
centrifugation, the cells were resuspended in
10 ml of medium (8 ml TC199 and 2 ml foetal
calf serum) containing 0.5 ,ug/ml colcemid,
and incubated at 37°C for 3 h. The cells were
fixed in 3:1 methanol:glacial acetic acid and
slides were stained using as light modification
of the G-banding technique of Gallimore and
Richardson (1973).
Photographs were made of all metaphases
which did not appear broken, and in which
the numbers of chromosomes could be
accurately counted. Karyotypes were pre-
pared from those cells which showed adequate
banding. The descriptions of the karyotypes
are in accordance with the recommendations
of the Paris Conference (1971).
RESULTS
(1) Histology and biochemistry
Histologically, both tumours were
poorly-differentiated adenocarcinomas,
with slightly moreglandulardifferentiation
in HxGC3. Both retained the histology of
the primary tumours through subsequent
xenografting, and continued to produce
epithelial mucins, CEA and human G6PD
and LDH isoenzymes (Houghton, 1977).
(2) The chromosomes
A few cells (<1%) were found with
normal mouse chromosome complements.
The remaining metaphases from both
tumours appeared to contain only human
chromosomes. To confirm that no mouse
elements were present in these cells, some
slides from each tumour, together with
slides of mouse marrow chromosomes as
controls, were stained using the alkaline
Giemsa ("GIl") technique described by
Friend, Chen and Ruddle (1976). With
this technique mouse chromosomes stain
magenta, human chromosomes blue. We
found no evidence for the presence of
mouse chromosomal material in the divid-
ing human tumour cells, either as whole
chromosomes or as interspecific trans-
locations.
(a) Chromosome numbers of the tumour
cells.-The distributions of chromosome
counts are shown in Table I. HxGC3 had
a mode of 46 in passage 3, and a mode of
47 in passage 11. In contrast, HxVRC5
was found to be hypodiploid, with a mode
of 41 in both passages 4 and 10.
(b) Chromosome analysis.-(i) HxGC3
(Table II)
In passage 3, 3 related cell lines were
recognized, within each ofwhich there was
little deviation from the modal karyotype.
The stemline (SL) karyotype was 46 X,
-Y, +12 (Fig. 1) while sideline (SDL) 1
was characterized by 46 X, -Y, -11,
+12, +mar 3, and SDL 2 by 46 X, -Y,
-10, +12, -13, +mar 1, +mar 2 (the
missing chromosome 13 probably being
included in marker 1). The shift of mode
to 47 by passage 11 was due to gain of a
chromosome 19 in the SL (Fig. 2). The
original SDL 1 was absent, while SDL 2
had evolved by gain of a number 10, loss
of a 15 and (as in the stemline) gain of
one number 19 (Fig. 3a). SDL 3 appeared
to be a derivative of SDL 2, but retained
TABLE L.-Distribution of Chromosome Counts
Tumour P
line
HxGC3
lass-
age
44
3 1
11 1
HxVRC5 40
4 8
10 4
L 45 46 47 48
5 21*
9 40* 3
41 42
23* 6
9* 3
49
2
Chromosome numbers
Numbers of cells
89 90 91 92 93 94
1 -- 3 -
- - 2 1 1 4
74 75 76 77 78 79 80 81 82 83
- 1 - - 2 1- 1 2 1
1 - - - 2 -
* Modal number.
Total
31
63
84
1
2
85
1 47
21
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TABLE II.-Analysis of Rel
Karyotypes from HxG(
Passage Chromosome
no. analysis
SL 46,X, -Y,+12
3 SDL1 46, X, -Y, -11,
+ 12, +mar 3
SDL2 46, X, -Y, -10,
+12, -13, +mar 1,
+mar 2
SL 47, X, -Y, + 12, + 19
SDL2 47, X, -Y, + 12,
11 -13, -15, +19,
+mar 1. +mar 2
SDL3 47, X, -Y, + 12,
-13, +19, +mar 1
SL Stemline SDL =Sideline *
both number 15s, also containe
19 and had lost marker 2 (Fig.
None of the polyploid cells f
passage could be completely anm
their karyotypes were sufficient
to allow assignment to particul;
(ii) HxVRC5
Cells from this tumour conl
normal chromosomes and, w]
presentative structurally abnormal chromosomes could
/3 be at least partly described, up to 30
No. ofcells/ unidentified markers were found. All the
line (%) mitoses differed slightly and in Fig. 4(a)
15+4* (68) is shown a representative cell from passage
5 (18) 4, with 40 chromosomes including the
4 (14) following structural abnormalities: t(lp+
;?) (pll or 13;?), del (3) (p13), del (3)
24+4*(58) (qll), del (6) (q16 or 21), t(7q+;?) (q3;?),
5 (11) t(llq+;?) (q2;?), t(12q+;?) (q2;?),
t(16p+;?) (pl;?), del (17) (pll or 12),
11+4* (31) t(22q+;?) (ql3;?), +25 markers. Ex-
amples of abnormal chromosomes from
Polyploids 3 other cells are shown in Fig. 4(b).
The similar morphology of many of the
d an extra smaller markers made their identification
3b). difficult from cell to cell, but markers 1-7
rom either were easily recognized, and of these,
alysed, but marker 5 is of particular interest. In 80%
tly distinct of the cells in passage 4, its morphology
ar lines. was as shown in Fig. 4(a) and 4(b) (iii);
in the remaining cells it had a short-arm
deletion, mar 5p-- (arrowed in Fig. 4(b)
tained few (ii)). By passage 10 all the cells contained
hilst some the marker only in the deleted form.
FIG. 1.-Stemline karyotype of HxGC3 from passage 3.
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FIG. 2. Stemline karyotype of HxGC3 from passage 11.
Apart from this instance, no other obvious
selection had taken place during serial
transfer.
(c) Cell fusion.-An interesting finding
in both tumour lines was of occasional
cells (<1%) containing normally con-
densed metaphase chromosomes together
with sets of chromosomes showing pre-
mature chromosome condensation (PCC)
a consequence of cell fusion. In cells which
fuse at different stages of the cell cycle,
e.g. S and G2 or M, mitosis in the more
advanced nucleus induces PCC in the
other (Johnson and Rao, 1970). Figs. 5(a)
and (b) show examples from HxVRC5
and HxGC3 respectively.
DISCUSSION
The 2 tumour lines studied were cyto-
genetically quite different. HxGC3 was
pseudodiploid in the early passage, with 3
chromosomally related lines containing
relatively few rearrangements. By passage
11 the mode had shifted to 47; SDL1 was
not represented but, remarkably, the
stemline and 2 sidelines had evolved by
each gaining a number 19 chromosome.
In contrast, HxVRC5 retained its mode
at 41 throughout and was notable for the
gross chromosomal rearrangements that it
contained, making identification of all but
a few elements impossible. Although the X
chromosome could not be identified, the
tumour continued to produce human
G6PD, an enzyme known to be coded by a
gene on the long-arm of the X (Baltimore
Conference, 1975) indicating that at least
part of that chromosome was present and
functional. This tumour was also shown
to have evolved during serial passage, with
selection for a line containing a particular
marker with a short-arm deletion (Figs.
4(a) and (b)). Other changes may have
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FIG. 3.-(a) Sideline 2 karyotype of HxGC3 from passage 11. (b) D-group and marker 1
from HxGC3, sideline 3. Note 2 normal number 15s.
taken place during transplantation, but
were not recognized due to similarities
in size and staining patterns between the
small markers.
Unfortunately, we were unable to make
direct chromosome preparations from
either of the primary tumours, and thus
we do not know if the original karyotypes
differ from those found in the early
passages. Visfeldt, Povlsen and Rygaard
(1972) attempted serial chromosome ana-
lysis ofseveral human colonic tumours and
melanomas heterotransplanted into nude
mice. However, banding techniques were
not used and few cells were suitable for
analysis, so that no firm conclusions could
be reached with regard to chromosome
changes which may have taken place
during transplantation.
Future studies of human solid-tumour
xenografts, using the new chromosome
staining techniques, may indicate whether
any particular chromosomes are involved
preferentially in karyotype evolution (as
suggested in the case of HxGC3). Some
caution may be necessary in interpreting
such changes since, in the heterotransplant
situation, the pressures on tumours (and
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hence their biological behaviour) are rather
different from those in the patient. There
is usually little tendency to metastasize
and the doubling time may be more rapid,
probably due to reduced cell loss (Lamer-
ton and Steel, 1975) which, in turn, may be
accounted for by a general lack of normal
tissue response in xenografts. Levan and
Mitelman (1976), in their study of G-
banded preparations from Rous-sarcoma-
virus-induced rat tumours passaged in rat
hosts, have shown, however, that non-
random sequential chromosomechanges do
occur regularly, even when a marked host-
derived stromal reaction is present.
Once a tumour line has been established,
it is clearly of prime importance to ensure
that the graft retains its human character-
istics, including a human karyotype, since
there is evidence that heterotransplanta-
tion may occasionally induce tumours in
the host (Houghton, 1977). Other evidence,
both biochemical (Goldenberg, Bahn and
Pavia, 1971) and cytogenetic (Janzen,
Millman and Thurston, 1971; Wiener
et al., 1972; Goldenberg, Pavia and Tsao,
1974) indicates that heterokaryons may
sometimes be formed between tumour
grafts and host cells, although this has
not been reported in systems using
immune-deprived mice.
In both the lines described here, the
readiness of the tumour cells to fuse with
one another, indicates not only that this
may have been a relatively important
mechanism of polyploidization, but that
there was also a high risk of fusion with
host cells, though there was no evidence
of products of interspecific cell hybrid-
ization.
PROSPECTS
There is a pressing need for systematic
cytogenetic studies of human solid
tumours. We have found that the main
difficulty in such studies, obtaining suffi-
cient numbers ofsuitable metaphases, may
be largely overcome using a xenograft
system. Such systems appear to hold
great promise for the study ofsolid tumour
karyotypes: new insight should be ob-
tained into the ways tumours evolve
FIG. 4. HxVRC5 (a) Karyotype of a representative cell with 40 chromosomes from passage 4.
(b) Examples of abnormal chromosomes selected from 3 cells.
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FIG. 5.-Examples of cells containing prematurely condensed chromosomes, the results of (a) fusion
of 2 near-diploid cells from HxVRC5 and (b) fusion of 2 polyploid cells from HxGC3.
cytogenetically, and the opportunity to
attempt to correlate karyotype changes
with biochemical and other parameters is
particularly exciting.
It is also clear that chromosome studies
should play an important part in any
programme concerned with the funda-
mental biology of xenografts.
We should like to thank Dr S. D. Lawler for her
helpful comments on the manuscript.
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